End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56 CNY | +1.21% | -1.25% | +13.94% |
26/04 | Yunnan Baiyao Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | Yunnan Baiyao Group Co.,Ltd. Approves Cash Dividend for the Year 2023 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.94% | 13.62B | C+ | ||
+25.83% | 661B | C+ | ||
+26.74% | 566B | B | ||
-6.71% | 352B | C+ | ||
+19.04% | 332B | B- | ||
+3.27% | 283B | C+ | ||
+13.43% | 231B | B+ | ||
+4.71% | 200B | B- | ||
-9.53% | 195B | A+ | ||
-4.22% | 145B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 000538 Stock
- Ratings Yunnan Baiyao Group Co.,Ltd